Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (921) Arrow Down
Filter Results: (921) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (921)
    • People  (2)
    • News  (122)
    • Research  (725)
    • Events  (14)
    • Multimedia  (1)
  • Faculty Publications  (397)

Show Results For

  • All HBS Web  (921)
    • People  (2)
    • News  (122)
    • Research  (725)
    • Events  (14)
    • Multimedia  (1)
  • Faculty Publications  (397)
← Page 16 of 921 Results →
  • 29 Oct 2024
  • HBS Seminar

Lynn Wu, Wharton

  • 14 Nov 2017
  • First Look

New Research and Ideas: November 14, 2017

through three examples: the design of medical residency matching programs, a scrip system to allocate food donations to food banks, and the recent "Incentive Auction" that reallocated wireless spectrum from television broadcasters to telecoms. Our lead examples show... View Details
Keywords: Carmen Nobel
  • September–October 2020
  • Article

The Past, Present, and (Near) Future of Gene Therapy and Gene Editing

By: Julia Pian, Amitabh Chandra and Ariel Dora Stern
Emerging gene therapy and gene-editing technologies will have a growing impact on patient lives and health-care delivery. We analyzed a decade of data on clinical trials and venture capital investments to understand the likely trajectory of genetically focused... View Details
Keywords: Gene Therapy; Gene Editing; Impact; Health Care and Treatment; Technological Innovation; Health Testing and Trials; Venture Capital; Change
Citation
Find at Harvard
Read Now
Related
Pian, Julia, Amitabh Chandra, and Ariel Dora Stern. "The Past, Present, and (Near) Future of Gene Therapy and Gene Editing." NEJM Catalyst Innovations in Care Delivery 1, no. 5 (September–October 2020).
  • 01 Jun 2011
  • Working Paper Summaries

The First Deal: The Division of Founder Equity in New Ventures

Keywords: by Thomas F. Hellmann & Noam Wasserman
  • 10 Feb 2016
  • HBS Seminar

Chris Blattman, Associate Professor, Columbia SIPA

  • 05 May 2009
  • First Look

First Look: May 5, 2009

  Working PapersRegional Trade Integration and Multinational Firm Strategies Authors:Pol Antrás and C. Fritz Foley Abstract This paper analyzes the effects of the formation of a regional trade agreement on the level and nature of... View Details
Keywords: Martha Lagace
  • January 2020
  • Article

The Market Reacts Quickly: Changes in Paclitaxel Vascular Device Purchasing Within the Ascension Healthcare System

By: Peter P. Monteleone, Subhash Banerjee, Priya Kothapalli, Ariel Dora Stern, Daniel Fehder, Ron Ginor, Dominic Vollmar, Edward T. A. Fry and Mark J. Pirwitz
Background. A meta-analysis of trials in endovascular therapy suggested an increased mortality associated with treatment exposure to paclitaxel. Multiple publications and corrections of prior data were performed, and the United States Food and Drug Administration has... View Details
Keywords: Medical Devices; Health Testing and Trials; Analysis; Sales
Citation
Read Now
Related
Monteleone, Peter P., Subhash Banerjee, Priya Kothapalli, Ariel Dora Stern, Daniel Fehder, Ron Ginor, Dominic Vollmar, Edward T. A. Fry, and Mark J. Pirwitz. "The Market Reacts Quickly: Changes in Paclitaxel Vascular Device Purchasing Within the Ascension Healthcare System." Journal of Invasive Cardiology 32, no. 1 (January 2020).
  • Forthcoming
  • Book

Innovating in Healthcare: Creating Breakthrough Tech, Services, Drugs, Products, and Business Models

By: Regina E. Herzlinger
Innovating in Healthcare offers effective approaches for designing, reworking, and implementing innovative healthcare services, products, and business models. It will help anyone working in healthcare service or product development, from hospitals to startups,... View Details
Keywords: Health Care and Treatment; Service Delivery; Product Development; Business Model; Innovation and Invention; Health Industry
Citation
Purchase
Related
Herzlinger, Regina E. Innovating in Healthcare: Creating Breakthrough Tech, Services, Drugs, Products, and Business Models. Boston, MA: John Wiley & Sons, forthcoming.
  • October 2005 (Revised October 2008)
  • Case

Virginia Mason Medical Center

By: Richard M.J. Bohmer and Erika Ferlins
In 2000, Dr. Gary Kaplan became CEO of the Virginia Mason Medical Center in Seattle, Washington. The hospital was facing significant challenges: It was losing money for the first time in its history, staff morale had plummeted, and area hospitals presented ardent... View Details
Keywords: Health Care and Treatment; Management Analysis, Tools, and Techniques; Production; Organizational Change and Adaptation; Problems and Challenges; Quality; Competition; Seattle
Citation
Educators
Purchase
Related
Bohmer, Richard M.J., and Erika Ferlins. "Virginia Mason Medical Center." Harvard Business School Case 606-044, October 2005. (Revised October 2008.)
  • Article

Value of New Performance Information in Healthcare: Evidence from Japan

By: Susanna Gallani, Takehisa Kajiwara and Ranjani Krishnan
Mandatory measurement and disclosure of outcome measures are commonly used policy tools in healthcare. The effectiveness of such disclosures relies on the extent to which the new information produced by the mandatory system is internalized by the healthcare... View Details
Keywords: Value Of Information; Feedback; Patient Satisfaction; Healthcare; Health Care and Treatment; Satisfaction; Information; Measurement and Metrics; Performance Improvement
Citation
Find at Harvard
Read Now
Related
Gallani, Susanna, Takehisa Kajiwara, and Ranjani Krishnan. "Value of New Performance Information in Healthcare: Evidence from Japan." International Journal of Health Economics and Management 20, no. 4 (December 2020): 319–357.
  • September 2007
  • Case

Collaborating to Improve

By: Richard M.J. Bohmer and Ingrid M. Nembhard
Madison Memorial Hospital is deciding between a variety of quality improvement strategies. Highlights quality improvement collaborative—organized programs popularized by the Institute for Healthcare Improvement in which teams from multiple institutions work together to... View Details
Keywords: Health Care and Treatment; Service Delivery; Performance Improvement; Quality; Groups and Teams; Cooperation; Integration; Health Industry
Citation
Educators
Purchase
Related
Bohmer, Richard M.J., and Ingrid M. Nembhard. "Collaborating to Improve." Harvard Business School Case 608-054, September 2007.
  • March 2020
  • Case

Maven Clinic: Women's Health in the Digital Age

By: Ariel D. Stern and Sarah Mehta
In late 2017, Kate Ryder, the founder and CEO of digital women’s health telemedicine company Maven Clinic, faced an important decision. Maven offered both a direct to consumer (D2C) product that anyone could use to book virtual appointments with health practitioners... View Details
Keywords: Business Growth and Maturation; Business Model; Business Startups; Entrepreneurship; Health; Health Care and Treatment; Strategy; Information Technology; Applications and Software; Health Industry; Technology Industry; United States
Citation
Educators
Purchase
Related
Stern, Ariel D., and Sarah Mehta. "Maven Clinic: Women's Health in the Digital Age." Harvard Business School Case 620-035, March 2020.
  • 19 Dec 2023
  • Research & Ideas

$15 Billion in Five Years: What Data Tells Us About MacKenzie Scott’s Philanthropy

$25,000 of annual revenue Private foundations After removing these and a few other special cases for which tax data were not available, we were left with 1,625 organizations. Of these, 1,190 organizations disclosed the size of their gifts. It is too soon to gauge the... View Details
Keywords: by Matthew Lee, Brian Trelstad, and Ethan Tran
  • 02 Oct 2015
  • Working Paper Summaries

Is Mandatory Nonfinancial Performance Measurement Beneficial?

Keywords: by Susanna Gallani, Takehisha Kajiwara & Ranjani Krishnan; Health
  • January 2009
  • Case

When Supply is of Public Interest: Roche & Tamiflu

The case focuses on the challenges of Roche maintaining a supply network for a global influenza pandemic response initiative based on its antiviral drug Tamiflu. The Roche group is a 40 billion CHF company consisting of a pharmaceutical division and a diagnostic... View Details
Keywords: Global Strategy; Health Pandemics; Distribution; Logistics; Production; Supply Chain Management; Performance Capacity; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Watson, Noel H., Laura Rock Kopczak, and Prashant Yadav. "When Supply is of Public Interest: Roche & Tamiflu." Harvard Business School Case 609-061, January 2009.
  • 2001
  • Chapter

Publicly Funded Science and the Productivity of the Pharmaceutical Industry

By: Rebecca Henderson and Ian Cockburn
U.S. taxpayers funded $14.8 billion of health related research last year, four times the amount that was spent in 1970 in real terms. In this paper we evaluate the impact of these huge expenditures on the technological performance of the pharmaceutical industry. While... View Details
Keywords: Public Sector; Science-Based Business; Research and Development; Sovereign Finance; Pharmaceutical Industry
Citation
Find at Harvard
Read Now
Related
Henderson, Rebecca, and Ian Cockburn. "Publicly Funded Science and the Productivity of the Pharmaceutical Industry." In Innovation Policy and the Economy, Volume 1, edited by Adam B. Jaffe, Josh Lerner, and Scott Stern, 1–34. MIT Press, 2001.
  • 15 Mar 2016
  • First Look

March 15, 2016

presidential and parliamentary elections shows that voter registration requirements have significant effects on turnout, disproportionately discouraging marginalized citizens. We assigned 20,500 apartments to one control or six View Details
  • Web

Faculty & Advisors | MBA

way clinical trials bottlenecked the development of new treatments for patients, compelling him to start TrialSpark. TrialSpark is a tech-driven drug development company that can run higher quality clinical trials at a fraction of the... View Details
  • September 2022
  • Article

The Impact of Financial Assistance Programs on Health Care Utilization: Evidence from Kaiser Permanente

By: Alyce S. Adams, Raymond Kluender, Neale Mahoney, Jinglin Wang, Francis Wong and Wesley Yin
Most hospitals have financial assistance programs for low-income patients. We use administrative data from Kaiser Permanente to study the effects of financial assistance on health care utilization. Using a regression discontinuity design based on an income threshold... View Details
Keywords: Healthcare; Utilization; Financial Assistance; Health Care and Treatment; Social Issues; Poverty; Health Industry
Citation
Find at Harvard
Register to Read
Related
Adams, Alyce S., Raymond Kluender, Neale Mahoney, Jinglin Wang, Francis Wong, and Wesley Yin. "The Impact of Financial Assistance Programs on Health Care Utilization: Evidence from Kaiser Permanente." American Economic Review: Insights 4, no. 3 (September 2022): 389–407.
  • 02 Jan 2018
  • First Look

First Look at New Research and Ideas, January 3, 2018

Sources of Inefficiency in Health Care By: Chandra, Amitabh, and Douglas O. Staiger Abstract—In medicine, the reasons for variation in treatment rates across hospitals serving similar patients are not well understood. Some interpret this... View Details
Keywords: Sean Silverthorne
  • ←
  • 16
  • 17
  • …
  • 46
  • 47
  • →
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.